Copyright
©2010 Baishideng Publishing Group Co.
World J Cardiol. Sep 26, 2010; 2(9): 299-304
Published online Sep 26, 2010. doi: 10.4330/wjc.v2.i9.299
Published online Sep 26, 2010. doi: 10.4330/wjc.v2.i9.299
Characteristics | n = 76 |
Demographic data | |
Male/female | 53 (70)/23 (30) |
Median age (range, yr) | 69 (42-86) |
Current smoker | 35 (46) |
Comorbidities | |
Hypertension | 48 (63) |
Diabetes mellitus | 20 (26) |
Hyperlipidemia | 39 (51) |
Peripheral vascular disease | 4 (5.3) |
CVA/TIA | 5 (6.3) |
Drug treatment | |
Statin | 71 (93.4) |
Beta blocker | 71 (93.4) |
ACEI/ARB | 75 (99) |
Spironolactone | 40 (69) |
Diuretics | 9 (12) |
CCBs | 5 (6.6) |
Nitrates | 12 (16) |
- Citation: Schwartzenberg S, Afek A, Charach G, Rubinstein A, Ben-Shoshan Y, Kissil S, Maisel-Auslender S, Keren G, George J. Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome. World J Cardiol 2010; 2(9): 299-304
- URL: https://www.wjgnet.com/1949-8462/full/v2/i9/299.htm
- DOI: https://dx.doi.org/10.4330/wjc.v2.i9.299